Xenofon Baraliakos is Senior Consultant and Scientific Coordinator at the Rheumazentrum Ruhrgebiet in Herne, Germany, and Associate Professor of Internal Medicine and Rheumatology at the Ruhr-Universität Bochum in Bochum, Germany. He studied medicine at the universities of Magdeburg (1994–1996) and Berlin (1996–2000), both in Germany, and went on to earned his PhD degree (2005) with a thesis entitled “MRI examinations of the spine in patients with ankylosing spondylitis before and after therapy with the monoclonal anti-TNF-a antibody infliximab”. Dr Baraliakos received his official Board Degrees in orthopaedic surgery in 2007 and in internal medicine and rheumatology in 2014.
His research interests include clinical and academic research in the field of spondyloarthritides, with special emphasis on imaging outcomes and treatment of the disease. Dr Baraliakos won the EWRR Award in 2005, the EULAR Young Investigator Award in 2006 and 2008, the German patient’s AS Society Award in 2010, and the 2014 Award for Excellence in Clinical Research from the European Society for Clinical Investigation (ESCI), among others.
Dr Baraliakos is the current President of the Assessment of Spondyloarthritis International Society (ASAS), Chair of the European League Against Rheumatism (EULAR) Standing Committee on Musculoskeletal Imaging and a member of the EULAR Executive Committee. He is also a member of the American College of Rheumatology (ACR), the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and the German Society of Rheumatology. Finally, Dr Baraliakos is a reviewer and Associate Editor for numerous major rheumatological journals.
EM-31028 - Date of preparation: April 2020